Developers and laboratories that make diagnostic tests would be wise to engage with legislation reintroduced in the US Congress on 24 June that would create a new regulatory framework for the products.
That’s the message from Scott Danzis, a partner in the Washington, DC, office of the law firm Covington & Burling,...







